NovaBridge Biosciences (NBP) Return on Capital Employed (2020 - 2025)
NovaBridge Biosciences (NBP) reported Return on Capital Employed of 38.94% for Q4 2025, down 1494.0% year-over-year from 2.79% in Q4 2024, and down 153.3% quarter-over-quarter from 15.37% in Q3 2025.
NovaBridge Biosciences (NBP) Return on Capital Employed (2020 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Return on Capital Employed data on file, last reported at 38.94% in Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 38.94%, down 1494.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 38.94% (down 1494.0% YoY), and the FY2025 annual result was 44.95%, down 2674.0% from the prior year.
- Return on Capital Employed eased to 38.94% in Q4 2025 per NBP's latest filing, from 15.37% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 20278.23% in Q2 2023 and troughed at 38.94% in Q4 2025.
- A 3-year average of 2874.81% and a median of 23.73% in 2025 frame the typical range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 1811 bps in 2025 and fell as far as 1494 bps in 2025.
- A 3-year view of Return on Capital Employed shows it stood at 20278.23% in 2023, then tumbled by 100 bps to 24.01% in 2024, then slumped by 62 bps to 38.94% in 2025.
- Business Quant data shows NBP's Return on Capital Employed at 38.94% in Q4 2025, 15.37% in Q3 2025, and 19.04% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -107.40% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -50.43% |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -38.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.94% |
| Sep 30, 2025 | -15.37% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | -23.73% |
| Dec 31, 2024 | -24.01% |
| Sep 30, 2024 | -33.49% |
| Jun 30, 2023 | 20,278.23% |
| Dec 31, 2020 | 12,524.16% |